LITTLE FALLS, N.J.,
Jan. 4, 2012 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE:CMN) announced today that
Andrew A. Krakauer, President &
CEO, will be presenting at the Needham & Company, LLC
14th Annual Growth Conference. The formal presentation is scheduled
for 9:20 AM ET on Wednesday, January 11, 2012 at The New York
Palace Hotel, with a Q & A session immediately following the
presentation. In addition, Mr. Krakauer and Seth R. Segel, Executive Vice President, will be
available for separate one-on-one meetings during the day. The
presentation will be available on the Investor Relations section of
the Company's website: www.cantelmedical.com.
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE:CMN) is a leading provider of
infection prevention and control products in the healthcare market.
Our products include water purification equipment, sterilants,
disinfectants and cleaners, specialized medical device reprocessing
systems for endoscopy and renal dialysis, disposable infection
control products primarily for dental and GI endoscopy markets,
dialysate concentrates and other dialysis supplies, hollow fiber
membrane filtration and separation products for medical and
non-medical applications, and specialty packaging for infectious
and biological specimens. We also provide technical maintenance for
our products and offer compliance training services for the
transport of infectious and biological specimens. For further
information, visit the Cantel website at
http://www.cantelmedical.com.
SOURCE Cantel Medical Corp.